Our top pick for
Building a portfolio
CalAmp Corp is a communication equipment business based in the US. CalAmp shares (CAMP) are listed on the NASDAQ and all prices are listed in US Dollars. CalAmp employs 1,080 staff and has a trailing 12-month revenue of around USD$339 million.
|Latest market close||USD$9.69|
|52-week range||USD$3.7 - USD$11.29|
|50-day moving average||USD$9.3991|
|200-day moving average||USD$8.3503|
|Wall St. target price||USD$11.9|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$-0.158|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-01-14)||-8.67%|
|1 month (2020-12-22)||4.08%|
|3 months (2020-10-21)||18.03%|
|6 months (2020-07-21)||27.67%|
|1 year (2020-01-21)||-3.10%|
|2 years (2019-01-18)||-30.74%|
|3 years (2018-01-19)||23.11|
|5 years (2016-01-21)||17.26|
Valuing CalAmp stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of CalAmp's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
CalAmp's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.7742. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into CalAmp's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
CalAmp's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$4.5 million.
The EBITDA is a measure of a CalAmp's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$339 million|
|Gross profit TTM||USD$143.3 million|
|Return on assets TTM||-2.36%|
|Return on equity TTM||-71.32%|
|Market capitalisation||USD$346.8 million|
TTM: trailing 12 months
There are currently 1.2 million CalAmp shares held short by investors – that's known as CalAmp's "short interest". This figure is 3.6% up from 1.2 million last month.
There are a few different ways that this level of interest in shorting CalAmp shares can be evaluated.
CalAmp's "short interest ratio" (SIR) is the quantity of CalAmp shares currently shorted divided by the average quantity of CalAmp shares traded daily (recently around 205268.42105263). CalAmp's SIR currently stands at 5.89. In other words for every 100,000 CalAmp shares traded daily on the market, roughly 5890 shares are currently held short.
However CalAmp's short interest can also be evaluated against the total number of CalAmp shares, or, against the total number of tradable CalAmp shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case CalAmp's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 CalAmp shares in existence, roughly 30 shares are currently held short) or 0.0419% of the tradable shares (for every 100,000 tradable CalAmp shares, roughly 42 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against CalAmp.
Find out more about how you can short CalAmp stock.
We're not expecting CalAmp to pay a dividend over the next 12 months.
CalAmp's shares were split on a 2:1 basis on 25 March 1996. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your CalAmp shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for CalAmp shares which in turn could have impacted CalAmp's share price.
Over the last 12 months, CalAmp's shares have ranged in value from as little as $3.7 up to $11.29. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while CalAmp's is 2.4446. This would suggest that CalAmp's shares are significantly more volatile than the average for this exchange and represent a higher risk.
CalAmp Corp. provides in telematics systems, and software and subscription services in the United States, Europe, the Middle East, Africa, South America, Asia and Pacific Rim, and internationally. The company offers telematics products, including asset tracking units, mobile telematics devices, fixed and mobile wireless gateways, and routers; and stolen vehicle recovery products for the broader connected vehicle and Internet of Things market, which enable customers to optimize their operations by collecting, monitoring, and reporting business-critical information and desired intelligence from remote and mobile assets. It also provides CalAmp Telematics Cloud platform, such as cloud-based application enablement and telematics service platforms that facilitate integration of its own applications, as well as those of third parties, through open application programming interfaces; and software as a service applications. In addition, the company offers professional services, including project management, engineering services, installation services, and an on-going early warning automated notification service. It sells its products and services to customers in the automotive, insurance, transportation and logistics, government, and construction markets through direct sales organization, a channel partner program, and sales representatives, as well as its Websites and digital platform. The company was founded in 1981 and is headquartered in Irvine, California.
Everything we know about the NLS Pharmaceutics Ltd IPO, plus information on how to buy in.
Everything we know about the GitLab IPO, plus information on how to buy in.
Everything we know about the Longeveron LLC IPO, plus information on how to buy in.
Everything we know about the Signify Health Inc IPO, plus information on how to buy in.
Everything we know about the Biophytis SA IPO, plus information on how to buy in.
Everything we know about the NexImmune Inc IPO, plus information on how to buy in.
Everything we know about the Adagene Inc IPO, plus information on how to buy in.
Everything we know about the Cloopen Group Holding Limited IPO, plus information on how to buy in.
Everything we know about the Decipher Biosciences Inc IPO, plus information on how to buy in.
Everything we know about the Proterra IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.